WO1990006696A2
(en)
*
|
1988-12-19 |
1990-06-28 |
Praxis Biologics, Inc. |
Meningococcal class 1 outer-membrane protein vaccine
|
US7118757B1
(en)
|
1988-12-19 |
2006-10-10 |
Wyeth Holdings Corporation |
Meningococcal class 1 outer-membrane protein vaccine
|
CU22302A1
(es)
*
|
1990-09-07 |
1995-01-31 |
Cigb |
Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
|
ATE190502T1
(de)
|
1993-05-13 |
2000-04-15 |
American Cyanamid Co |
Herstellung und verwendungen von los-verminderten aussenmembran-proteinen von gram-negativen kokken
|
US6287574B1
(en)
|
1995-03-17 |
2001-09-11 |
Biochem Pharma Inc. |
Proteinase K resistant surface protein of neisseria meningitidis
|
DE69631835T3
(de)
*
|
1995-09-18 |
2009-03-05 |
United States Army Medical Research Materiel Command (Usamrmc) |
Verbesserte verfahren zur herstellung von nichtkovalent komplexierten und multivalenten impfstoffen gegen proteasomen-untereinheiten
|
FR2751000B1
(fr)
|
1996-07-12 |
1998-10-30 |
Inst Nat Sante Rech Med |
Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
|
US6558677B2
(en)
*
|
1996-10-15 |
2003-05-06 |
Wendell D. Zollinger |
Vaccine against gram negative bacteria
|
RU2347813C2
(ru)
*
|
1997-11-06 |
2009-02-27 |
Чирон С.П.А. |
Антигены нейссерий
|
GB9726398D0
(en)
|
1997-12-12 |
1998-02-11 |
Isis Innovation |
Polypeptide and coding sequences
|
GB9808734D0
(en)
*
|
1998-04-23 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9808866D0
(en)
|
1998-04-24 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9810276D0
(en)
*
|
1998-05-13 |
1998-07-15 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9811260D0
(en)
|
1998-05-26 |
1998-07-22 |
Smithkline Beecham Biolog |
Novel compounds
|
US10967045B2
(en)
|
1998-11-02 |
2021-04-06 |
Secretary of State for Health and Social Care |
Multicomponent meningococcal vaccine
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
CN1344322A
(zh)
*
|
1999-01-22 |
2002-04-10 |
史密丝克莱恩比彻姆生物有限公司 |
脑膜炎奈瑟氏菌basb055多核苷酸和多肽及其用途
|
NZ515935A
(en)
|
1999-05-19 |
2004-01-30 |
Chiron S |
Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
GB9929923D0
(en)
*
|
1999-12-17 |
2000-02-09 |
Baldwin Thomas J |
Antigen preparations
|
BRPI0112928B1
(pt)
*
|
2000-07-27 |
2017-08-29 |
Children's Hospital & Research Center At Oakland |
A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
DE60235155D1
(de)
*
|
2001-04-17 |
2010-03-11 |
Childrens Hosp Oak Res Inst |
Monoklonale antikörper gegen molekulare mimetika von meningokokken-b-epitopen
|
RU2355704C2
(ru)
*
|
2001-04-17 |
2009-05-20 |
Новартис Вэксинс Энд Диагностикс, Инк |
Моноклональное антитело, направленное против gna33 пептида, и его применение
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
IL145926A0
(en)
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
CU22983A1
(es)
*
|
2002-05-08 |
2004-09-09 |
Inst Finlay |
Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas
|
AU2003257003A1
(en)
*
|
2002-07-30 |
2004-02-16 |
Baxter Healthcare S.A. |
Chimeric multivalent polysaccharide conjugate vaccines
|
EP1524992B1
(en)
|
2002-08-02 |
2015-03-04 |
GlaxoSmithKline Biologicals s.a. |
Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria menigitidis
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
WO2004046177A2
(en)
|
2002-11-15 |
2004-06-03 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
CU23313A1
(es)
|
2002-11-27 |
2008-09-25 |
Inst Finlay Ct De Investigacia |
Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
|
CN102302776B
(zh)
|
2003-01-30 |
2014-06-18 |
诺华疫苗和诊断有限公司 |
抗多种脑膜炎球菌血清组的可注射性疫苗
|
US20040241190A1
(en)
*
|
2003-04-07 |
2004-12-02 |
Xenova Research Limited |
Vaccine preparations
|
RU2250113C2
(ru)
*
|
2003-06-04 |
2005-04-20 |
Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук |
Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
CU23420A1
(es)
*
|
2003-12-30 |
2009-09-08 |
Univ De Cambridge |
Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
GB0416120D0
(en)
|
2004-07-19 |
2004-08-18 |
Health Prot Agency |
Stable compositions containing OMV's
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
ES2616294T3
(es)
|
2005-01-27 |
2017-06-12 |
Children's Hospital & Research Center At Oakland |
Vacunas de vesículas basadas en GNA1870 para protección de amplio espectro contra enfermedades provocadas por Neisseria meningitidis
|
UA95238C2
(uk)
|
2005-06-27 |
2011-07-25 |
Ґлаксосмітклайн Байолоджікалз С.А. |
Імуногенна композиція
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
GB0605757D0
(en)
|
2006-03-22 |
2006-05-03 |
Chiron Srl |
Separation of conjugated and unconjugated components
|
US7943352B2
(en)
|
2006-03-29 |
2011-05-17 |
Bacoustics, Llc |
Apparatus and methods for vaccine development using ultrasound technology
|
US8414899B2
(en)
|
2006-04-11 |
2013-04-09 |
Yeda Research And Development Co. Ltd. |
Vaccines comprising multimeric HSP60 peptide carriers
|
WO2008095677A1
(en)
*
|
2007-02-07 |
2008-08-14 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Recombinant antigens of human cytomegalovirus (hcmv)
|
CA2716212A1
(en)
|
2008-02-21 |
2009-08-27 |
Novartis Ag |
Meningococcal fhbp polypeptides
|
CU20080215A7
(es)
|
2008-11-19 |
2012-06-21 |
Inst Finlay |
Vacunas unitemporales
|
EP3017828A1
(en)
|
2009-08-27 |
2016-05-11 |
GlaxoSmithKline Biologicals SA |
Hybrid polypeptides including meningococcal fhbp sequences
|
MX2012004850A
(es)
|
2009-10-27 |
2012-05-22 |
Novartis Ag |
Polipeptidos fhbp meningococicos modificados.
|
CN103002910A
(zh)
|
2010-03-10 |
2013-03-27 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗组合物
|
CU20100083A7
(es)
|
2010-05-05 |
2012-06-21 |
Inst Finlay |
Tolerogenos adyuvados como vacuna de malaria
|
FI3831406T3
(fi)
|
2010-08-23 |
2024-08-06 |
Wyeth Llc |
Neisseria meningitidis rlp2086 -antigeenien stabiileja formulaatioita
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
ES2864635T3
(es)
|
2010-09-10 |
2021-10-14 |
Wyeth Llc |
Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
|
CU20110202A7
(es)
|
2011-11-02 |
2013-12-27 |
Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas |
Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
MY198910A
(en)
|
2012-03-09 |
2023-10-02 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
EP2689775A1
(en)
|
2012-07-25 |
2014-01-29 |
Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros |
Cochleate with only one mamp
|
CA2903716C
(en)
|
2013-03-08 |
2019-04-09 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
AU2014316722B2
(en)
|
2013-09-08 |
2017-09-07 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
ES2841378T3
(es)
|
2014-02-28 |
2021-07-08 |
Glaxosmithkline Biologicals Sa |
Polipéptidos fHbp meningocócicos modificados
|
KR20170103009A
(ko)
|
2015-02-19 |
2017-09-12 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
CN118021947A
(zh)
|
2017-01-31 |
2024-05-14 |
辉瑞大药厂 |
脑膜炎奈瑟菌组合物及其使用方法
|
RU2659948C1
(ru)
*
|
2017-03-14 |
2018-07-04 |
Федеральное государственное бюджетное научноеучреждение "Омский аграрный научный центр" (ФГБНУ "Омский АНЦ") |
Способ получения R-бруцеллёзной сыворотки на кроликах
|
CN110157767A
(zh)
*
|
2019-04-18 |
2019-08-23 |
金花企业(集团)股份有限公司 |
一种转移因子口服溶液生物活性测定方法
|
MX2022003682A
(es)
|
2019-09-27 |
2022-04-25 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|